The interaction between diabetes and AD features (cognitive decline APOE ε4 carriership, cerebrospinal fluid β-amyloid, total tau (t-tau) and hyperphosphorylated-tau (p-tau) showed that individuals with both diabetes and at least one AD feature had a faster functional decline rate than those without both factors. Here, MAPT is linked to diabetes mellitus.